MJH Logo
Last Updated On: August 23, 2016
  • Access
  • Access
  • Insight
  • Education
  • Access
  • Insight
  • Education
  • Access
  • Insight
  • Education
Products, Services, & Partnerships
The future of Lung Cancer The future of Breast Cancer PER Event PER Event PER Event ONCLive SOSS AJMC AMCO SOGO NYGU NYGU PCDC Per Event 34 Chemotherapy Foundation VBOnc GBM SOBO Miami Lung Cancer Miami Breast Cancer Giants 2016 MD Mag Pharmacy Times Pharmacy Times RDR OncLive SAP Pharmacy Times
A Full-Service Healthcare Communications Company
 
Michael J. Hennessy Associates‚ Inc‚ is dedicated to providing healthcare professionals with the information and resources they need to optimize patient outcomes. As a full-service healthcare communications company‚ MJH Associates provides integrated communication products and services, education, and research to the healthcare industry. 
 
Within our integrated communications division, we feature an established‚ comprehensive network of print and digital products that reaches an impressive array of healthcare decision makers, including physicians, pharmacists, managed care professionals, PA/NPs, nurses, and patients. Michael J. Hennessy Associates, Inc, has a long-standing reputation for offering timely, relevant, and practical information that meets the needs of our diverse audience.
 
As a company, Michael J. Hennessy Associates, Inc, combines the reach and influence of its powerful portfolio of print and digital product line, live events, educational programs, and custom market research with the customer service focus and customization capabilities of a boutique firm. Our clients include world-leading pharmaceutical, medical device, diagnostic, and biotech companies within the industry.

Leading Brands, Broadest Reach
The American Journal of Accountable CareFamily Practice RecertificationThe American Journal of Managed CareThe American Journal of Pharmacy BenefitsArcmesaCardiology Review OnlineContemporary OncologyCure TodayDentists' Money DigestOncology Business ManagementPharmacy TimesGiants of Cancer CareOncology FellowsAmerican Journal of Hematology / OncologyInternal Medicine World ReporCure ConnectionsIntellisphereMD MagazineContemporary ClinicResident and Staff PhyisicianPhysician's Money DigestOncologueMedical CrossfireInteractive PublicationsSurgical RoundsPhysicians Financial newsMedical World NewsOncLiveEvidence-Based OncologyRare Disease CommunicationsPain ManagementPharmacy Times Continuing EducationOncLive InsightsRare Disease ReportThe Educated PatientOncology and Biotech NewsHRA ResearchOncLive News NetworkSpecialty Pharmacy TimesPhysicians Education ResourceOncLive Peer ExchangeUrologists in Cancer CareOncology Nursing NewsMD MagazineTargeted Oncology
The Latest
from MJH Associates

Berwick Tells AJMC Healthcare Spending Can Be 15% of GDP, "Without a Hint of Rationing"
Healthcare as we have known it doesn't work cooperatively, which is one reason it costs way too much, according to Donald M. Berwick, MD, MPP, president emeritus and senior fellow of the Institute for Healthcare Improvement and co-originator of the term the Triple Aim. Berwick spoke with The American Journal of Managed Care as it publishes reports on Aligning Forces for Quality, funded by the Robert Wood Johnson Foundation.

After a Decade of "Social Investment," the Quest to Improve Healthcare Continues
In 2006, the Robert Wood Johnson Foundation launched Aligning Forces for Quality, which sought to improve the quality of healthcare using a regional approach. Findings on this massive undertaking, introduced by Donald M. Berwick, MD, MPP, former CMS administrator, reaffirm both the importance and challenge of implementing healthcare reform.

AJMC Review Finds Drug Exclusions May Cut Costs Without Harming Patients
As the nation's largest pharmacy benefit managers leave more therapies off formularies, some ask: are patients harmed? A new review in The American Journal of Managed Care, covering 26 studies about drug exclusions, found that most policies saved money without fallout for patients -- but there were some exceptions.


Our Audience